Activation of HIV Transcription by the Viral Tat Protein Requires a Demethylation Step Mediated by Lysine-specific Demethylase 1 (LSD1/KDM1)

English version České info

The essential transactivator function of the HIV Tat protein is regulated by multiple posttranslational modifications. Although individual modifications are well characterized, their crosstalk and dynamics of occurrence during the HIV transcription cycle remain unclear.

We examine interactions between two critical modifications within the RNA-binding domain of Tat:
monomethylation of lysine 51 (K51) mediated by Set7/9/KMT7, an early event in the Tat transactivation cycle that strengthens the interaction of Tat with TAR RNA, and acetylation of lysine 50 (K50) mediated by p300/KAT3B, a later process that dissociates the complex formed by Tat, TAR RNA and the cyclin T1 subunit of the positive transcription elongation factor b (P-TEFb). We find K51 monomethylation inhibited in synthetic Tat peptides carrying an acetyl group at K50 while acetylation can occur in methylated peptides, albeit at a reduced rate. To examine whether Tat is subject to sequential monomethylation and acetylation in cells, we performed mass spectrometry on immunoprecipitated Tat proteins and generated new modification-specific Tat antibodies against monomethylated/acetylated Tat. No bimodified Tat protein was detected in cells pointing to a demethylation step during the Tat transactivation cycle. We identify lysine-specific demethylase 1 (LSD1/KDM1) as a Tat K51-specific demethylase, which is required for the activation of HIV transcription in latently infected T cells. LSD1/KDM1 and its cofactor CoREST associates with the HIV promoter in vivo and activate Tat transcriptional activity in a K51-dependent manner. In addition, small hairpin RNAs directed against LSD1/KDM1 or inhibition of its activity with the monoamine oxidase inhibitor phenelzine suppresses the activation of HIV transcription in latently infected T cells.

Our data support the model that a LSD1/KDM1/CoREST complex, normally known as a transcriptional suppressor, acts as a novel activator of HIV transcription through demethylation of K51 in Tat. Small molecule inhibitors of LSD1/KDM1 show therapeutic promise by enforcing HIV latency in infected T cells.

Vyšlo v časopise: Activation of HIV Transcription by the Viral Tat Protein Requires a Demethylation Step Mediated by Lysine-specific Demethylase 1 (LSD1/KDM1). PLoS Pathog 7(8): e32767. doi:10.1371/journal.ppat.1002184
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002184

Souhrn

Zdroje

1. HanYWind-RotoloMYangHCSilicianoJDSilicianoRF 2007 Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 5 95 106

2. NoeAPlumJVerhofstedeC 2005 The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance. J Antimicrob Chemother 55 410 412

3. BlazkovaJTrejbalovaKGondois-ReyFHalfonPPhilibertP 2009 CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5 e1000554

4. KauderSEBosqueALindqvistAPlanellesVVerdinE 2009 Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5 e1000495

5. TreandCdu CheneIBresVKiernanRBenarousR 2006 Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter. EMBO J 25 1690 1699

6. AgbottahEDengLDannenbergLOPumferyAKashanchiF 2006 Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription. Retrovirology 3 48

7. MahmoudiTParraMVriesRGKauderSEVerrijzerCP 2006 The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J Biol Chem 281 19960 19968

8. Van LintCEmilianiSOttMVerdinE 1996 Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15 1112 1120

9. ImaiKTogamiHOkamotoT 2010 Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285 16538 16545

10. OttMSchnolzerMGarnicaJFischleWEmilianiS 1999 Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 9 1489 1492

11. KiernanREVanhulleCSchiltzLAdamEXiaoH 1999 HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 18 6106 6118

12. PagansSPedalANorthBJKaehlckeKMarshallBL 2005 SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 3 e41

13. BresVKiernanRELinaresLKChable-BessiaCPlechakovaO 2003 A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter. Nat Cell Biol 5 754 761

14. BoulangerMCLiangCRussellRSLinRBedfordMT 2005 Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 79 124 131

15. Van DuyneREasleyRWuWBerroRPedatiC 2008 Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. Retrovirology 5 40

16. PagansSKauderSEKaehlckeKSakaneNSchroederS 2010 The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 7 234 244

17. WeiPGarberMEFangSMFischerWHJonesKA 1998 A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92 451 462

18. LiangCWainbergMA 2002 The role of Tat in HIV-1 replication: an activator and/or a suppressor? AIDS Rev 4 41 49

19. WeinbergerLSDarRDSimpsonML 2008 Transient-mediated fate determination in a transcriptional circuit of HIV. Nat Genet 40 466 470

20. HetzerCDormeyerWSchnolzerMOttM 2005 Decoding Tat: the biology of HIV Tat posttranslational modifications. Microbes Infect 7 1364 1369

21. HauberJMalimMHCullenBR 1989 Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol 63 1181 1187

22. ColECaronCSeigneurin-BernyDGraciaJFavierA 2001 The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J Biol Chem 276 28179 28184

23. DorrAKiermerVPedalARackwitzHRHenkleinP 2002 Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J 21 2715 2723

24. MujtabaSHeYZengLFarooqACarlsonJE 2002 Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell 9 575 586

25. KaehlckeKDorrAHetzer-EggerCKiermerVHenkleinP 2003 Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell 12 167 176

26. BresVTagamiHPeloponeseJMLoretEJeangKT 2002 Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J 21 6811 6819

27. OttMDorrAHetzer-EggerCKaehlckeKSchnolzerM 2004 Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found Symp: 259 182 193; discussion 193-186, 223-185

28. IvanovGSIvanovaTKurashJIvanovAChuikovS 2007 Methylation-acetylation interplay activates p53 in response to DNA damage. Mol Cell Biol 27 6756 6769

29. KurashJKLeiHShenQMarstonWLGrandaBW 2008 Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo. Mol Cell 29 392 400

30. DengLde la FuenteCFuPWangLDonnellyR 2000 Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 277 278 295

31. JordanABisgroveDVerdinE 2003 HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22 1868 1877

32. PagansSSakaneNSchnoelzerMOttM 2011 Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies. Methods 53 91 6

33. ShiYJMatsonCLanFIwaseSBabaT 2005 Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19 857 864

34. LeeMGWynderCSchmidtDMMcCaffertyDGShiekhattarR 2006 Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13 563 567

35. HakimiMADongYLaneWSSpeicherDWShiekhattarR 2003 A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes. J Biol Chem 278 7234 7239

36. HumphreyGWWangYRussanovaVRHiraiTQinJ 2001 Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J Biol Chem 276 6817 6824

37. YouATongJKGrozingerCMSchreiberSL 2001 CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci U S A 98 1454 1458

38. CulhaneJCWangDYenPMColePA 2010 Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 132 3164 3176

39. MimasuSUmezawaNSatoSHiguchiTUmeharaT 2010 Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1. Biochemistry 49 6494 6503

40. BindaCValenteSRomanenghiMPilottoSCirilliR 2010 Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2. J Am Chem Soc 132 6827 6833

41. SwiggardWJBaytopCYuJJDaiJLiC 2005 Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli. J Virol 79 14179 14188

42. TianXFangJ 2007 Current perspectives on histone demethylases. Acta Biochim Biophys Sin (Shanghai) 39 81 88

43. ShiYLanFMatsonCMulliganPWhetstineJR 2004 Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 941 953

44. MetzgerEWissmannMYinNMullerJMSchneiderR 2005 LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437 436 439

45. HuangJSenguptaREspejoABLeeMGDorseyJA 2007 p53 is regulated by the lysine demethylase LSD1. Nature 449 105 108

46. KontakiHTalianidisI 2010 Lysine methylation regulates E2F1-induced cell death. Mol Cell 39 152 160

47. WangJHeviSKurashJKLeiHGayF 2009 The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 41 125 129

48. NicholsonTBChenT 2009 LSD1 demethylates histone and non-histone proteins. Epigenetics 4 129 132

49. LiangYVogelJLNarayananAPengHKristieTM 2009 Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat Med 15 1312 1317

50. MarbanCSuzanneSDequiedtFde WalqueSRedelL 2007 Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26 412 423

51. ZhouMDengLLacosteVParkHUPumferyA 2004 Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. J Virol 78 13522 13533

52. ZhouGTeDRoizmanB 2010 The CoREST/REST Repressor Is both Necessary and Inimical for Expression of Herpes Simplex Virus Genes. MBio 2 e00313 10

53. GrskovicMChaivorapolCGaspar-MaiaALiHRamalho-SantosM 2007 Systematic identification of cis-regulatory sequences active in mouse and human embryonic stem cells. PLoS Genet 3 e145

54. VenturaAMeissnerADillonCPMcManusMSharpPA 2004 Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci U S A 101 10380 10385

55. HellmanNESpectorJRobinsonJZuoXSaunierS 2008 Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J Biol Chem 283 4272 4282

56. GuWRoederRG 1997 Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90 595 606

57. RoepstorffPFohlmanJ 1984 Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom 11 601